Skip to main content
. 2020 Dec 14;10(4):2045894020977025. doi: 10.1177/2045894020977025

Table 3.

Patients achieving low-risk status over time for the BEAT cohort.

Week 16 Week 21 Week 30
REVEAL 2.0 (N)
Low-risk, n (%)
73
31 (42.5)
70
37 (52.9)
66
41 (62.1)
French noninvasive (N)
3 low-risk criteria, n (%)
73
0 (0)
71
4 (5.6)
66
9 (13.6)

REVEAL: Registry to Evaluate Early and Long-term PAH disease management.

Notes: REVEAL 2.0 scores of ≤5 were considered “low” risk. Achieving 3 low-risk criteria by the French noninvasive method was considered “low” risk.